Primary Immunoglobulin A Nephropathy (IgAN) Clinical Trials in Hangzhou, Zhejiang

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN